Front Burner Why is the U.K. rethinking puberty blockers?
11 snips
Dec 16, 2025 
Azeen Ghorayshi, a science and gender reporter for The New York Times, dives into the heated debate surrounding puberty blockers for minors. She explains how these drugs can pause puberty for those with gender dysphoria and discusses their potential benefits and risks. Ghorayshi highlights the controversial findings of the Cass review, which questioned the quality of existing evidence. As the U.K. embarks on new clinical trials, she emphasizes the urgent need for clear information for families navigating this complex issue.
AI Snips
Chapters
Transcript
Episode notes
How Puberty Blockers Work
- Puberty blockers pause physical puberty by suppressing testosterone and estrogen.
- They provide reversible pause and time for young people to consider future treatment decisions.
Blockers Often Start A Treatment Pathway
- Puberty blockers link to subsequent hormone therapy, making fertility loss a potential risk if hormones continue.
- That sequential use makes treatment outcomes different from treating precocious puberty.
Major Long-Term Risks Remain Unclear
- Key unknowns include effects on bone density, fertility, and brain development when puberty is paused.
- Puberty is a rapid developmental period so interrupting it raises major unanswered questions.